17-Jul-2012 - Carl Zeiss AG

Carl Zeiss Licences Digital Pathology from Olympus

Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

Facts, background information, dossiers
More about Carl Zeiss
  • News

    Changes to Executive Board of Carl Zeiss AG

    President and CEO of Carl Zeiss Meditec AG, Dr. Ludwin Monz, has announced to the Supervisory Board that he will not be accepting another term in office. The Supervisory Board notes his decision with regret. Dr. Monz and the Supervisory Board have agreed to end his term on 31 December 2021. ... more

    ZEISS Reports Successful Start to Fiscal Year

    The ZEISS Group had a successful end to the first six months of fiscal year 2020/21 (ended 31 March 2021). It saw its revenue rise by 6 percent (adjusted for currency fluctuations, by 9 percent) to 3.406 billion euros (previous year: 3.213 billion euros). Around 90% of this sum was generate ... more

    ZEISS Invests by Acquiring Majority Stake in arivis AG

    ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image pro ... more

  • Videos

    Your Inverted Microscope Platform with AI Assisted Experiment Startup

    Axio Observer is your stable inverse platform for demanding multimodal imaging of living and fixed specimens. Featuring the AI Sample Finder for optimal user guidance and operation, Axio Observer makes sample placement easier than ever and reduces the time to image from minutes to just seco ... more

    Carl Zeiss Microscopy GmbH

    more

    Your Smart Microscope for Easy Digital Documentation

    Combine Axiolab 5 with the microscope camera Axiocam 208 color and take full advantage of the smart microscopy concept: you'll be experiencing a completely new form of digital documentation. Just focus your sample and press a single button for crisp images in true color. The digital image w ... more

  • Companies

    Carl Zeiss Vision GmbH

    Having been founded in 2005, Carl Zeiss Vision is the new leader in ophthalmic products. We provide the consumer and the eyecare professional with quality spectacle lenses, diagnostic tools, services and support in business and marketing. more

    Carl Zeiss AG

    Carl Zeiss AG is a leading group of companies operating worldwide in the optical and opto-electronic industry. The five independently operating business groups are active in the future-oriented markets of Medical and Research Solutions, Industrial Solutions and Lifestyle Products. Founded i ... more

    Carl Zeiss Jena GmbH

    Carl Zeiss designs and manufactures spectral sensors from 0.9-2.2 µm. We also deliver On-line, At-line and In-Line spectrometer systems for concentration, layer thickness and colour measurement. Specially configurations for pharma and food industry. more

More about Olympus